Search research articles
Contact Us
Filters
Showing results (171-180 of 581) with videos related to
Page
of 59
Sort By:
Cancer
|
January 21, 2000
Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues
S S Chang, V E Reuter, W D Heston, et al.
British Journal of Urology
|
November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer
A G Aprikian, W R Fair, V E Reuter, et al.
The Journal of Urology
|
February 8, 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer
Harry W Herr, Bernard H Bochner, Guido Dalbagni, et al.
Cancer Research
|
December 1, 1993
Allelic deletions in renal tumors: histopathological correlations
J C Presti, V E Reuter, C Cordon-Cardo, et al.
Journal of Pathology Informatics
|
June 19, 2026
Comparative analysis of whole-slide scanner tissue detection algorithms: Implications for scan area, scan time, and file size in high-volume digital pathology workflows
K Hasan Bilal, Kaitlyn Gelfant, Allyne Manzo, et al.
Urology
|
December 12, 2002
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome
James McKiernan, Ofer Yossepowitch, Michael W Kattan, et al.
Journal of the National Cancer Institute
|
March 2, 1994
Clinical relevance of the i(12p) marker chromosome in germ cell tumors
G J Bosl, D H Ilson, E Rodriguez, et al.
Oncogene
|
April 12, 2006
ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression
L Peduto, V E Reuter, A Sehara-Fujisawa, et al.
Genes, Chromosomes & Cancer
|
July 1, 1991
Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridization
A B Mukherjee, V V Murty, E Rodriguez, et al.
Clinical Therapeutics
|
January 11, 2018
Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer
Catherine J Lucas, Peter Galettis, Shuzhen Song, et al.
Page
of 59
Search research articles
Search
Showing results (171-180 of 581) with videos related to
Sort By:
Page
of 59
Cancer
|
January 21, 2000
Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues
S S Chang, V E Reuter, W D Heston, et al.
British Journal of Urology
|
November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer
A G Aprikian, W R Fair, V E Reuter, et al.
The Journal of Urology
|
February 8, 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer
Harry W Herr, Bernard H Bochner, Guido Dalbagni, et al.
Cancer Research
|
December 1, 1993
Allelic deletions in renal tumors: histopathological correlations
J C Presti, V E Reuter, C Cordon-Cardo, et al.
Journal of Pathology Informatics
|
June 19, 2026
Comparative analysis of whole-slide scanner tissue detection algorithms: Implications for scan area, scan time, and file size in high-volume digital pathology workflows
K Hasan Bilal, Kaitlyn Gelfant, Allyne Manzo, et al.
Urology
|
December 12, 2002
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome
James McKiernan, Ofer Yossepowitch, Michael W Kattan, et al.
Journal of the National Cancer Institute
|
March 2, 1994
Clinical relevance of the i(12p) marker chromosome in germ cell tumors
G J Bosl, D H Ilson, E Rodriguez, et al.
Oncogene
|
April 12, 2006
ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression
L Peduto, V E Reuter, A Sehara-Fujisawa, et al.
Genes, Chromosomes & Cancer
|
July 1, 1991
Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridization
A B Mukherjee, V V Murty, E Rodriguez, et al.
Clinical Therapeutics
|
January 11, 2018
Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer
Catherine J Lucas, Peter Galettis, Shuzhen Song, et al.
Page
of 59